Vaxcyte, Inc. is a pharmaceutical company based in the United States of America with a medium risk rating score of 26.3. Specializing in vaccines, Vaxcyte Inc. is dedicated to enhancing global health through the development of innovative vaccines to combat prevalent and severe diseases. Their product lineup includes the Pneumococcal conjugate vaccine as well as promising candidates like VAX-24, VAX-A1, and VAX-PG. Improve your healthcare strategy with Vaxcyte, a company committed to ESG practices and sustainability.